Evidence map›Paper›PMID 40371204›Full record

ArticleAnnals of gastroenterology

Malek Shatila, Gabriel Sperling, Antonio Pizuorno Machado, Muhammad Vohra, Elliot Baerman, Enrico N De Toni, Helga-Paula Török, Dan Zhao, Yan Zhou, Mehnaz A Shafi and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Malek ShatilaDepartment of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (Malek Shatila, Mehnaz A. Shafi, Anusha Shirwaikar Thomas, Mazen Alasadi, Yinghong Wang).
Gabriel SperlingDepartment of Internal Medicine, The University of Texas Medical Branch, Galveston, TX, USA (Gabriel Sperling).
Antonio Pizuorno MachadoDepartment of Internal Medicine, The University of Texas Health Science Center, Houston, TX, USA (Antonio Pizuorno Machado, Muhammad Vohra).
Muhammad VohraDepartment of Internal Medicine, The University of Texas Health Science Center, Houston, TX, USA (Antonio Pizuorno Machado, Muhammad Vohra).
Elliot BaermanDepartment of Internal Medicine, Baylor College of Medicine, Houston, TX, USA (Elliot Baerman).
Enrico N De ToniDepartment of Medicine II, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany (Enrico N. De Toni, Helga-Paula Török).
Helga-Paula TörökDepartment of Medicine II, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany (Enrico N. De Toni, Helga-Paula Török).
Dan ZhaoDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (Dan Zhao).
Yan ZhouDepartment of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (Yan Zhou).
Mehnaz A ShafiDepartment of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (Malek Shatila, Mehnaz A. Shafi, Anusha Shirwaikar Thomas, Mazen Alasadi, Yinghong Wang).
Anusha Shirwaikar ThomasDepartment of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (Malek Shatila, Mehnaz A. Shafi, Anusha Shirwaikar Thomas, Mazen Alasadi, Yinghong Wang).
Mazen AlasadiDepartment of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (Malek Shatila, Mehnaz A. Shafi, Anusha Shirwaikar Thomas, Mazen Alasadi, Yinghong Wang).
Yinghong WangDepartment of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (Malek Shatila, Mehnaz A. Shafi, Anusha Shirwaikar Thomas, Mazen Alasadi, Yinghong Wang).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: This single-center, retrospective study included patients with gastric adenocarcinoma between June 1985 and August 2022. Patients with different histological subtypes were excluded. Primary variables of interest included Results: A total of 2930 patients were included, of whom 206 (7.0%) received ICIs, 196 (6.7%) had prior Conclusions: These findings suggest

Indexed as

gastric cancerHelicobacter pyloriimmunotherapy

Identifiers

PMID40371204
PMCPMC12070332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.